Supernus Pharmaceuticals Insider Sold Shares Worth $4,536,250, According to a Recent SEC Filing-February 2024-www.financetom.com

Supernus Pharmaceuticals Insider Sold Shares Worth $4,536,250, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Supernus Pharmaceuticals Insider Sold Shares Worth $4,536,250, According to a Recent SEC Filing

Nov 12, 2024 2:08 PM

04:30 PM EST, 11/12/2024 (MT Newswires) -- Jack A. Khattar, Director, President, CEO, on November 08, 2024, sold 125,000 shares in Supernus Pharmaceuticals ( SUPN ) for $4,536,250. Following the Form 4 filing with the SEC, Khattar has control over a total of 1,948,622 shares of the company, with 926,172 shares held directly and 1,022,450 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1356576/000162828024047142/xslF345X05/wk-form4_1731445884.xml

Previous page： Singtel falls up to 3% after $2.3 billion impairment Next page： Vivendi says feasibility study for planned split is in progress

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Singtel falls up to 3% after $2.3 billion impairment

Apr 28, 2024

(Reuters) -Shares of Singapore Telecommunications (Singtel) fell as much as 3.3% on Monday to a more than one-week low after it forecast non-cash impairment provisions of S$3.1 billion ($2.28 billion) for the second half of 2024. The impairment provisions would lead to the telecom giant reporting a net loss for the second-half period and a lower net profit for the...

Vivendi says feasibility study for planned split is in progress

Apr 28, 2024

(Reuters) - French media conglomerate Vivendi said on Monday that a feasibility study for the plan to split its business into four separate companies was progressing. The option currently being examined is a partial split of Vivendi, where Canal+, Havas, and a company grouping its assets in publishing and distribution would become independently listed entities, while Vivendi would stay listed...

Agrochemicals company Syngenta posts big drop in Q1 sales, earnings

Apr 28, 2024

ZURICH (Reuters) -Seeds and pesticides maker Syngenta suffered big drops in first quarter sales and profit, the company said on Monday, just a few weeks after the Swiss company shelved its plans for a $10 billion flotation. Sales fell 20% to $7.4 billion, Syngenta said, while core operating profit (EBITDA) declined by 34% to $1.2 billion, as farmers continued to...

Abu Dhabi sovereign fund ADQ picks banks for two-part bond sale, IFR reports

Apr 28, 2024

April 29 (Reuters) - Abu Dhabi sovereign wealth fund, Abu Dhabi Developmental Holding (ADQ), has hired banks to arrange investor meetings ahead of its debut U.S. dollar denominated double tranche bond offering, fixed income news service IFR reported on Monday. The fund has picked Citigroup ( C/PN ), Credit Agricole, First Abu Dhabi Bank, Goldman Sachs International, HSBC ( HSBC...